✦ LIBER ✦

A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer

✍ Scribed by Martin, Miguel; Bonneterre, Jacques; Geyer, Charles E.; Ito, Yoshinori; Ro, Jungsil; Lang, Istvan; Kim, Sung-Bae; Germa, Caroline; Vermette, Jennifer; Wang, Kenneth; Wang, Kongming; Awada, Ahmad

Book ID: 122873521
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 539 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2013.07.142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Trial of Sunitinib in Combinat

Phase III Trial of Sunitinib in Combination With Capecitabine Versus Capecitabine Monotherapy for the Treatment of Patients With Pretreated Metastatic Breast Cancer

✍ Crown, J. P.; Dieras, V.; Staroslawska, E.; Yardley, D. A.; Bachelot, T.; Davids 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 192 KB

Phase III randomized trial of sunitinib

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

✍ Carlos H. Barrios; Mei-Ching Liu; Soo Chin Lee; Laurence Vanlemmens; Jean-Marc F 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 289 KB

Phase II trial of a novel capecitabine d

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB

PO59 EFFICACY AND SAFETY OF EVEROLIMUS P

PO59 EFFICACY AND SAFETY OF EVEROLIMUS PLUS EXEMESTANE COMBINATION THERAPY VERSUS MONOTHERAPY WITH EVEROLIMUS OR CAPECITABINE IN HR+, HER2− BREAST CANCER: A MULTI-CENTER, OPEN-LABEL, PHASE 2 TRIAL BOLERO-6

✍ de Boer, Richard; Jerusalem, Guy; Hurvitz, Sara; Ejlertsen, Bent; El-Hashimy, Mo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Capecitabine/cisplatin versus 5-fluorour

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

✍ Kang, Y.-K.; Kang, W.-K.; Shin, D.-B.; Chen, J.; Xiong, J.; Wang, J.; Lichinitse 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 331 KB

Survival update of so14999 a large phase

Survival update of so14999 a large phase III trial of capecitabine/doxetaxel combination therapy vs docetaxel monotherapy in patients with locally advanced (LABC) or metastatic breast cancer (MBC)

✍ R. Leonard; G. Cervantes; W. Lui; L. Mauriac; D. Miles; V. Moiseyenko; C. Chan N 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 190 KB